Rating History for Bicara Therapeutics Inc (BCAX) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/20/2026 | Sean Laaman | New Coverage | Overweight (N/A) |
41.00 (N/A) |
16.78 (17.07) |
1.73% | Details |
 |
|||||||
|
|||||||
|
|||||||
